ReviewJournal of immunology research2020

Activating the Antitumor Immune Response in Non-Hodgkin Lymphoma Using Immune Checkpoint Inhibitors.

Maansi Joshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.